https://safirsoft.com FDA advisers unanimously place modern Greena boosters at high risk for people over 65

It is recommended that modern speakers use the same qualified Pfizer loudspeaker groups. As expected, a panel of independent Food and Drug Administration (FDA) advisors unanimously (19-0) noon today in favor of licensing a booster dose of the COVID-19 Moderna vaccine for select groups.

Specific groups for reinforcement: People 65 years of age or older, 18-64 years of age at risk for COVID-19, and people 18-64 years old at risk of contracting COVID due to repeated organizational or occupational exposure 19 are present. , such as health care and essential workers. These are the same groups that were previously allowed to have the Pfizer/BioNTech booster.

Like Pfizer/BioNTech boosters, Moderna boosters should be prescribed six months or more after the first dose. Moderna mRNA vaccine. A notable difference from Moderna's recommendation is that the booster dose is half the dose of the first two doses - the 50 mcg dose instead of the 100 mcg dose. The doses used in the first and second pictures. In data submitted to the U.S. Food and Drug Administration before today's meeting, Moderna said lower doses were as effective as larger doses, but likely to have fewer side effects in particular, the company said. A twofold or greater increase in antibody levels among clinical trial participants. Mild COVID-19 infections decline over time, and older, high-risk groups may become more susceptible to developing serious illness over time (although protections against hospitalization and death are strong at the moment). Under these circumstances, combined with good safety and efficacy information, the Food and Drug Administration - VRBPAC - has strongly supported the provision of booster doses to select groups.

Objectives

As in the panel discussions on the Pfizer/BioNTech amplifier, VRBPAC members strongly opposed opening the amplifier to all—something the Biden government would like to do. Members reiterated their ongoing protection against hospitalization and death among young people, who are also at increased risk of certain complications, such as myocarditis (inflammation of the heart). “Of course you absolutely do not agree to [provide a booster] for up to 18 years,” said Paul Avit, VRBPAC voting member and pediatric infectious disease specialist at Children's Hospital of Philadelphia. "I was impressed that Avite said in a post-election discussion that we still have excellent protection against moderate to severe disease in this country through the Delta and for all age groups." And I think we keep sending the wrong messages with phrases like "progress" and making people feel unprotected unless they get a third dose. “Vaccines, he and others argued, are intended to prevent the worst outcomes — severe illness and death — from mild infections,” Avit said. Infections are always expected at some levels, he said. In addition, this goal and Offit pressure added that fortification of all vaccinators deviates from the most important goal, noting that “the problem in this country is not vaccinating people.” They launched an initial trial that showed mixing vaccines and adapting it as better protection than using the same type of booster vaccine.Although this study was small, it indicated that a Moderna booster might provide the strongest protection, independent of the original vaccination.However, the trial was conducted shorter after the first dose ( increase after 12 weeks, not after six months), and a dose greater than 100 mcg was used for the boosters.

VRBPAC meets again tomorrow to discuss compound and match data as well as Johnson & Johnson vaccine booster data. In the meantime, it was decided The FDA will decide whether to sign off on VRBPAC's recommendations for licensing Moderna Booster today, which it likely will. Next, the Centers for Disease Control and Prevention and its advisory committee speak with more advice about who should get boosters.< /p>

FDA advisers unanimously place modern Greena boosters at high risk for people over 65
fda-advisers-unanimously-place-modern-greena-boosters-at.html

https://safirsoft.com 300-year-old tree rings confirm recent increase in rainfall

300-year-old tree rings confirm recent increase in rainfall

For at least a century, there has been no such thing as these hurricane seasons. Like many other types of weather, tropical storms and hurricanes have...
https://safirsoft.com Microplastics may cool or warm the Earth's climate

Microplastics may cool or warm the Earth's climate

Small plastic pieces circling in the sky can affect the weather. Like ash from a volcanic cloud, microplastics polluted the atmosphere and surrounded ...
https://safirsoft.com Luxo, Jr. And Mystic develops new methods to deform materials

Luxo, Jr. And Mystic develops new methods to deform materials

Two new articles highlight promising ways to change structures. 1932. Nearly ninety years later, according to a new research paper published in the Pr...
https://safirsoft.com Zooniverse wants to turn you into a planet hunter

Zooniverse wants to turn you into a planet hunter

Scientists ask people to help find the right signals. If you've ever wanted

to explore faraway worlds, now's the time. The team behind the constell...

https://safirsoft.com How SpaceX lights up a new Raptor engine in Starship without an explosion

How SpaceX lights up a new Raptor engine in Starship without an explosion

So why don't all rocket engines have giant nozzles? For the first time, the company's engineers ignited a vacuum version of the Raptor rocket engine t...
https://safirsoft.com Missile report: South Korea recently lost its orbit, Ariane 5, to record the payload

Missile report: South Korea recently lost its orbit, Ariane 5, to record the payload

"We don't see any significant positive catalyst for the stock."

Welcome to version 4.21 of the Missile Report! There's a lot of news this wee...